David Bienvenue BS, PhD

Dr. Bienvenue is currently a Senior Director at Aptevo Therapeutics, where he manages the Protein Sciences group and leads the Early Product Development (EPD) team. His team focuses on the stability and manufacturability of ADAPTIR bispecific proteins to identify lead clinical candidates.